Similar articles for PMID: 17320951

Year	Number of Results
1958	1
1993	1
1999	1
2001	1
2002	1
2004	3
2005	3
2006	5
2007	20
2008	18
2009	15
2010	4
2011	4
2012	3
2013	3
2014	4
2015	5
2016	3
2017	2
2018	2
2020	1
2021	3
2022	2
2024	0

1

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature.

Musto P, Scalzulli PR, Terruzzi E, Rossini F, Iacopino P, Messina G, Guariglia R, Pietrantuono G, Villani O, D'Auria F, Falcone A, Sanpaolo G, Valvano MR, Pogliani EM, Morabito F. Musto P, et al. Leuk Res. 2007 Nov;31(11):1487-93. doi: 10.1016/j.leukres.2007.01.008. Epub 2007 Feb 23. Leuk Res. 2007. PMID: 17320951

2

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Viola A, Delia R, Carbone A, Celentano M. Ferrara F, et al. Hematol Oncol. 2011 Sep;29(3):139-43. doi: 10.1002/hon.978. Epub 2010 Nov 30. Hematol Oncol. 2011. PMID: 21922508 Clinical Trial.

3

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.

Zappasodi P, Nosari AM, Astori C, Ciapanna D, Bonfichi M, Varettoni M, Mangiacavalli S, Morra E, Lazzarino M, Corso A. Zappasodi P, et al. Transfusion. 2008 May;48(5):857-60. doi: 10.1111/j.1537-2995.2007.01621.x. Epub 2008 Feb 1. Transfusion. 2008. PMID: 18248573 Clinical Trial.

4

Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.

Orciuolo E, Buda G, Marturano E, Mauro E, Milone G, Cangialosi C, Di Renzo N, Pastore D, Specchia G, De Paolis MR, Mazza P, Pietrantuono G, Petrini M. Orciuolo E, et al. Leuk Res. 2011 Jul;35(7):899-903. doi: 10.1016/j.leukres.2010.10.029. Epub 2010 Dec 4. Leuk Res. 2011. PMID: 21134693 Free article. Clinical Trial.

5

Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.

Fenk R, Hieronimus N, Steidl U, Bruns I, Graef T, Zohren F, Ruf L, Haas R, Kobbe G. Fenk R, et al. Exp Hematol. 2006 Oct;34(10):1296-302. doi: 10.1016/j.exphem.2006.06.002. Exp Hematol. 2006. PMID: 16982322 Free article.

6

Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.

Fruehauf S, Klaus J, Huesing J, Veldwijk MR, Buss EC, Topaly J, Seeger T, Zeller LW, Moehler T, Ho AD, Goldschmidt H. Fruehauf S, et al. Bone Marrow Transplant. 2007 Jun;39(12):743-50. doi: 10.1038/sj.bmt.1705675. Epub 2007 Apr 23. Bone Marrow Transplant. 2007. PMID: 17450182 Clinical Trial.

7

Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.

Vanstraelen G, Frère P, Ngirabacu MC, Willems E, Fillet G, Beguin Y. Vanstraelen G, et al. Exp Hematol. 2006 Mar;34(3):382-8. doi: 10.1016/j.exphem.2005.11.013. Exp Hematol. 2006. PMID: 16543072 Free article. Clinical Trial.

8

Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Piccirillo N, De Matteis S, De Vita S, Laurenti L, Chiusolo P, Sorà F, Reddiconto G, d'Onofrio G, Leone G, Sica S. Piccirillo N, et al. Bone Marrow Transplant. 2007 Sep;40(6):579-83. doi: 10.1038/sj.bmt.1705772. Epub 2007 Jul 16. Bone Marrow Transplant. 2007. PMID: 17637690 Clinical Trial.

9

A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantation.

Khot A, Dickinson M, Stokes K, Harrison S, Burbury K, Fleming S, Wall D, Gambell P, Prince HM, Seymour JF, Ritchie D. Khot A, et al. Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):42-7. doi: 10.1016/j.clml.2012.09.017. Epub 2012 Nov 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23146384

10

Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas.

Ballestrero A, Boy D, Gonella R, Miglino M, Clavio M, Barbero V, Nencioni A, Gobbi M, Patrone F. Ballestrero A, et al. Ann Hematol. 2008 Jan;87(1):49-55. doi: 10.1007/s00277-007-0366-7. Epub 2007 Aug 21. Ann Hematol. 2008. PMID: 17710398 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year